Target type: biologicalprocess
The process in which heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring, is transported from one side of a membrane to the other by means of some agent such as a transporter or pore. [GOC:bf]
Heme transmembrane transport is a crucial process for maintaining cellular heme homeostasis and is essential for various physiological functions. Heme, a porphyrin ring complex containing ferrous iron, plays a vital role in oxygen transport, electron transfer, and enzymatic catalysis.
The transport of heme across cellular membranes is mediated by specific transmembrane proteins, known as heme transporters. These proteins are highly conserved across different organisms and exhibit diverse mechanisms of action.
**1. ABC Transporters:**
* ABC (ATP-binding cassette) transporters are a large family of transmembrane proteins that utilize ATP hydrolysis to transport various substrates across membranes.
* Several ABC transporters have been identified to be involved in heme transport, including ABCG2 (also known as BCRP), ABCB6, and ABCB7.
* These transporters are involved in the efflux of heme from cells, contributing to heme homeostasis and preventing accumulation of toxic levels of heme.
**2. HRG1 (Heme Responsive Gene 1):**
* HRG1 is a transmembrane protein that facilitates the influx of heme into cells.
* It belongs to the major facilitator superfamily (MFS) of transporters.
* HRG1 plays a significant role in heme uptake by erythroid cells, which are responsible for red blood cell production.
**3. FLVCR1 (Feline Leukemia Virus C Receptor 1):**
* FLVCR1 is a transmembrane protein that acts as a heme exporter, transporting heme from cells.
* It is involved in heme export from various cell types, including erythroid cells, macrophages, and hepatocytes.
* FLVCR1 plays a crucial role in regulating intracellular heme levels and preventing heme accumulation.
**4. Other Transporters:**
* Other proteins, such as the mitochondrial heme transporter (MTH), are involved in the specific transport of heme across mitochondrial membranes.
* MTH is crucial for delivering heme to the mitochondrial heme biosynthesis pathway.
**Mechanism of Heme Transport:**
* The exact mechanisms of heme transport by different transporters vary depending on the specific protein.
* Some transporters, like ABCG2, utilize ATP hydrolysis to actively transport heme across membranes.
* Other transporters, like HRG1, may rely on concentration gradients or other cellular signaling pathways to facilitate heme transport.
**Regulation of Heme Transport:**
* Heme transport is tightly regulated to maintain cellular heme homeostasis.
* Factors like cellular heme levels, oxygen availability, and specific cellular signals influence the expression and activity of heme transporters.
* Dysregulation of heme transport can lead to various pathological conditions, such as anemia, porphyrias, and cancer.
**Conclusion:**
* Heme transmembrane transport is a complex process involving multiple proteins with diverse mechanisms of action.
* These transporters play crucial roles in maintaining cellular heme homeostasis and supporting various physiological functions.
* Understanding the mechanisms of heme transport is essential for developing therapeutic strategies for diseases related to heme metabolism.'
"
Protein | Definition | Taxonomy |
---|---|---|
Multidrug resistance-associated protein 5 | An ATP-binding cassette sub-family C member 5 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O15440] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
dilazep | dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties. Dilazep: Coronary vasodilator with some antiarrhythmic activity. | benzoate ester; diazepane; diester; methoxybenzenes | cardioprotective agent; platelet aggregation inhibitor; vasodilator agent |
dipyridamole | dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots. Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) | piperidines; pyrimidopyrimidine; tertiary amino compound; tetrol | adenosine phosphodiesterase inhibitor; EC 3.5.4.4 (adenosine deaminase) inhibitor; platelet aggregation inhibitor; vasodilator agent |
sulfinpyrazone | Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. | pyrazolidines; sulfoxide | uricosuric drug |
trequinsin | trequinsin: RN given refers to parent cpd; structure given in first source | pyridopyrimidine | |
l 660,711 | quinolines | ||
cyclic gmp | 3',5'-cyclic GMP : A 3',5'-cyclic purine nucleotide in which the purine nucleobase is specified as guanidine. Cyclic GMP: Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) | 3',5'-cyclic purine nucleotide; guanyl ribonucleotide | Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite |
sildenafil | sildenafil : A pyrazolo[4,3-d]pyrimidin-7-one having a methyl substituent at the 1-position, a propyl substituent at the 3-position and a 2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl group at the 5-position. | piperazines; pyrazolopyrimidine; sulfonamide | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent |